NR1H4 and metabolic dysfunction-associated steatohepatitis: These hydrophobic bile acids are particularly effective in activating the TGR5 receptor (75), which may lead to decreased activity of FXR and subsequent increase of de novo bile acid synthesis as described in patients with MASH compared with healthy controls (76).